Researchers have demonstrated that a brand-new, targeted therapy drug can lengthen the course of treatment for people with glioma subtypes without the cancer getting worse. The discovery points to a potential new treatment option for those who have the deadly brain tumor that is slowly growing.
New drug delays progression of glioma, a deadly brain cancer
